logo
These invasive, wasp-like insects are eating Pierce County pine trees

These invasive, wasp-like insects are eating Pierce County pine trees

Yahoo02-06-2025
You may notice a pine sawfly on your pine trees this spring or summer. The pesky creatures are more disturbance than damage, but The News Tribune has gathered advice on what to do about them.
A common type of pine sawfly people are likely dealing with in Pierce County is the European sawfly, said entomologist and director of Washington State University's Puyallup Research and Extension Center Todd Murray.
He said he's seen pine hedges in the area being fed on by sawflies, which are a wasp-like insect. They are an invasive species from Europe, and were first documented in Washington state around 2008, Murray said. The sawflies feed on pine needles, sometimes causing bare spots on trees that can be striking, but do not cause critical tree damage, Murray added.
'They aren't really tree killers, they're not a species that's a major concern,' he said. 'They just take the needles away.'
He said pine sawflies also lay their eggs in pine needles, and these egg-positing wounds can be spotted on the foliage. As they get bigger, larvae begin to feed on the needles, making their presence more obvious. Since larvae typically live in big groups, the best way to rid a plant of them is to remove them physically, Murray said.
'They're aggregate feeders, they like to hang out together and eat,' he said. 'If you can reach into bushes within arm's length, you can knock the larvae right off the tree physically, into a bucket of soapy water.'
He said some people may also use insecticide to keep the insects away from their plants, but the bugs aren't deadly to pine trees. Birds are the main predator for pine sawflies, so people can also allow nature to take its course, he added.
For those who feel they have an annual issue with the insects, Murray suggested scouting recent pine needle growth for egg-positing wounds and using that information to see when larvae will eventually develop, to be prepared to remove them.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Natera initiates trial of Signatera test for breast cancer
Natera initiates trial of Signatera test for breast cancer

Yahoo

time2 hours ago

  • Yahoo

Natera initiates trial of Signatera test for breast cancer

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at replacing chemotherapy with endocrine therapy before surgery in certain breast cancer patients. The multicentre, randomised controlled trial (RCT) focuses on women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-negative breast cancer who are responsive to endocrine treatment and test negative with Signatera. Academic research organisation Austrian Breast & Colorectal Cancer Study Group sponsored the trial, which plans to enrol 250 subjects across 15 Austrian sites. This trial seeks to assess the endocrine therapy's efficacy in comparison to chemotherapy in those who are Signatera-negative, to minimise the use of pre-operative chemotherapy and its associated side effects. After receiving an endocrine therapy course for four weeks, subjects who remain Signatera-negative and exhibit a favourable response as per the Ki-67 proliferation index measurement are set to be randomised to continue with endocrine therapy or chemotherapy. The primary goal of the TEODOR trial is the response rate to neoadjuvant therapy, gauged by pathological complete response (pCR) and modified Preoperative Endocrine Prognostic Index (PEPI) score, across endocrine and chemotherapy trial arms. Secondary goals encompass long-term effects such as recurrence of breast cancer and overall survival rates. Signatera is a custom-built blood test for identifying molecular residual disease (MRD) in the form of circulating tumour DNA. Natera oncology medical director Angel Rodriguez said: 'With the TEODOR trial, our goal is to identify patients who may be able to safely forgo chemotherapy. 'We are proud to collaborate with ABCSG on this important trial, and we hope this study will support the role of Signatera in guiding neoadjuvant therapy in breast cancer.' The test is covered by Medicare for those with stage IIb and higher breast cancer. In May 2025, Natera announced outcomes from a study assessing the Signatera MRD test in those with soft tissue and bone sarcomas. "Natera initiates trial of Signatera test for breast cancer" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

Experts issue warning after beachcombers make unexpected discovery on US coastline: 'They will continue to spread'
Experts issue warning after beachcombers make unexpected discovery on US coastline: 'They will continue to spread'

Yahoo

time4 hours ago

  • Yahoo

Experts issue warning after beachcombers make unexpected discovery on US coastline: 'They will continue to spread'

Experts issue warning after beachcombers make unexpected discovery on US coastline: 'They will continue to spread' Beachcombers in Ketchikan, Alaska, found shells of invasive European green crabs on a sandy state park shore in June, making this the newest location in a fight with these harmful non-native species, reported the Alaska Beacon. What's happening? The shells were found during a beach survey June 6 as part of a University of Alaska Southeast class. After this first find, more shells turned up at other spots along Ketchikan's road system. These crabs first showed up in Alaska in 2022 on Annette Island, about 30 miles south of the recent Ketchikan find. The Metlakatla Indian Community has caught around 3,000 of these invasive crabs since they were first spotted, with more than 300 trapped on nearby Gravina Island just last month. "They have continued to spread. They will continue to spread," said Barbara Morgan, a UAS professor who helped lead the beach surveys, per the Beacon. "They are expected to spread through Southeast Alaska, probably most of Southcentral — kind of the southern coast of Southcentral." Why are invasive green crabs concerning? These destructive crabs threaten Alaska's marine ecosystem and fishing industry. They eat salmon fry, young Dungeness crabs, and other native fish species. They also destroy eelgrass beds, which serve as essential habitats for many fish species, including commercially valuable salmon. The National Oceanic and Atmospheric Administration warns Alaskans that green crabs "could potentially damage Alaska's multibillion-dollar fisheries industries, especially for salmon, crab, and mariculture operations." What's being done about invasive species? The Metlakatla Indian Community leads Alaska's most active response effort, establishing a detection program in 2020 that has trapped thousands of green crabs. This "functional eradication" approach focuses on protecting key sites vital to native species, such as salmon and Dungeness crab. The Alaska Invasive Species Partnership coordinates broader work among government agencies, university experts, nonprofits, and community organizations, per the Beacon. It advocates for establishing a stronger state invasive species council to coordinate broader protection and facilitate a quicker response. Bills now in the Alaska Legislature would create such a council. The House approved earlier attempts but didn't reach final approval before the sessions ended, per the Beacon. If you spot what might be a European green crab, you can help by learning to identify them correctly. They have five spikes on each side of their shells and three bumps between their eyes. They can be green, brown, yellow, reddish, or a combination of these colors. Contact your local wildlife office if you spot suspicious crabs or shells. Supporting laws for invasive species control can also help shield Alaska's valuable marine ecosystems and the communities that rely on them. Do you worry about companies drilling too deep into the ground? Definitely Depends on what it's for Only if it's near my home Not really Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword

Video/Pic: Trump demands drug companies lower prices
Video/Pic: Trump demands drug companies lower prices

American Military News

time6 hours ago

  • American Military News

Video/Pic: Trump demands drug companies lower prices

President Donald Trump sent 17 pharmaceutical companies letters on Thursday and demanded that the companies lower prices for Americans. The president warned that the 'unacceptable burden' of prescription drug prices will 'end' with his administration. During a press briefing on Thursday, White House Press Secretary Karoline Leavitt said, 'The president signed an executive order earlier this year to solve the problem of exorbitant pharmaceutical pricing.' 'According to recent data, the prices that Americans have been paying for brand-name drugs are more than three times the price other similarly developed nations pay,' Leavitt added. 'The president is determined to solve this problem and took further action today. He has signed 17 letters to pharmaceutical companies' CEOs.' .@PressSec reads one of the letters sent by @POTUS today to the CEOs of pharmaceutical companies: "Moving forward, the only thing I will accept from drug manufacturers is a commitment that provides American families immediate relief from the vastly inflated drug prices…" — Rapid Response 47 (@RapidResponse47) July 31, 2025 Leavitt also shared the letter Trump wrote to the CEO of Eli Lilly and Company. In the letter, Trump warned Eli Lilly and 16 other pharmaceutical companies that the 'unacceptable burden' of brand-name drugs costing 'up to three times higher on average' for Americans than for citizens of other countries 'ends with my administration.' Trump told the pharmaceutical companies, 'Most proposals the Trump administration has received to resolve this critical issue promised more of the same shifting blame and requesting policy changes that would result in billions of dollars in handouts to industry.' The president added, 'Moving forward, the only thing I will accept from drug manufacturers is a commitment that provides American families immediate relief from the vastly inflated drug prices and an end to the free ride of American innovation by European and other developed nations.' READ MORE: Video: Trump order against 'Big Pharma' aims to reduce drug prices While Trump explained that a collaborative effort to reach 'global pricing parity' would be most effective for pharmaceutical companies, the U.S. government, and U.S. patients, he warned that his administration will 'deploy every tool in our arsenal to protect American families' if pharmaceutical companies refuse to take action. In addition to the letter sent to Eli Lilly and Company, Trump sent letters to AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, EMD Serono, Genentech, Gilead Sciences, GSK, Johnson and Johnson, Merck, Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals, and Sanofi. In the letters, Trump gave the companies 60 days to extend 'Most-Favored-Nation' pricing to Medicaid and provide 'full portfolios' of drugs for Medicaid patients, guarantee Most-Favored-Nation pricing for new drugs, negotiate with 'foreign freeloading nations' and return 'increased revenues abroad' to patients in the United States, and allow Americans to directly purchase drugs at Most-Favored-Nation prices. Today, @POTUS sent letters to 17 drug manufacturers outlining steps they must take to bring down prescription drug prices. If they refuse to step up, the Administration will use every tool to protect Americans from continued abusive drug pricing practices. Letter to Eli Lilly: — Rapid Response 47 (@RapidResponse47) July 31, 2025

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store